Evidence map›Paper›PMID 35175611›Full record

ArticleAdvances in experimental medicine and biology2022

Graphene-Based Materials for Efficient Neurogenesis.

Yeon-Woo Cho, Kwang-Ho Lee, Tae-Hyung Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yeon-Woo ChoSchool of Integrative Engineering, Chung-Ang University, Seoul, South Korea.
Kwang-Ho LeeSchool of Integrative Engineering, Chung-Ang University, Seoul, South Korea.
Tae-Hyung KimSchool of Integrative Engineering, Chung-Ang University, Seoul, South Korea. thkim0512@cau.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene, a two-dimensional plane-structured carbon allotrope, has outstanding properties. Owing to their unique features, graphene-based materials including graphene derivatives have recently emerged as an ideal material and been used in various fields. Especially, in terms of specific advantages of graphene including great electrical conductivity, high potential to conjugate with biomolecules, and applicability to three-dimensional structures, neurogenesis-based stem cell therapies using graphene-based materials have been reported to be a candidate of treatment for neurodegenerative disease (e.g., Parkinson's disease, Alzheimer's disease, and Huntington's disease). To date, extensive studies on neurogenesis-based stem cell therapies including enhanced neural differentiation and monitoring stem cells behavior have been conducted using graphene-based materials. Herein, we have summarized recent various studies of neurogenesis using graphene-based materials in depth and focused on effect of graphene on functional improvement of neural stem cells and monitoring of differentiation into neural linages.

Indexed as

GraphiteNeural Stem CellsNeurodegenerative DiseasesCell DifferentiationHumansNeurogenesisGraphiteGrapheneGraphene-based materialsNeurogenesis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.